12882_2019_1226_MOESM1_ESM.docx (150.83 kB)
Additional file 1: of Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study
journal contribution
posted on 2019-02-18, 05:00 authored by Dimitrios Chanouzas, Julie McGregor, Peter Nightingale, Alan Salama, Wladimir Szpirt, Neil Basu, Matthew Morgan, Caroline Poulton, Juliana Draibe, Elizabeth Krarup, Paula Dospinescu, Jessica Dale, William Pendergraft, Keegan Lee, Martin Egfjord, Susan Hogan, Lorraine HarperTables S1. Intravenous pulse methylprednisolone use and dosage. Table S2. Cyclophosphamide and oral prednisolone dose in intravenous pulse methylprednisolone (MP) and non-MP treated patients. Table S3. Factors associated with infection at 3 months on univariable and multivariable proportional hazards analysis. Figure S1. Time to infection by 3 months (A) and from 3 to 12 months (B) and time to severe infection by 3 months (C) and from 3 to 12 months (D) was examined by Kaplan-Meier curve analysis. Time to infection for patients that received MP is shown in the dashed line and that for non-MP treated patients in the solid line. (DOCX 150 kb)
